Showing posts with label Child Psychiatry. Show all posts
Showing posts with label Child Psychiatry. Show all posts

Friday, August 31, 2018

Large Increase In Poison Control Calls for Children Taking ADHD Drugs

madinamerica
Peter Simons
August 28, 2018

New data shows that calls to US poison control centers have increased significantly for children taking stimulant ADHD drugs.

New research published in the journal Pediatrics has found that calls to US poison control centers have increased significantly due to children taking ADHD stimulant medications, such as amphetamine (Adderall) and methylphenidate (Ritalin). The research was led by Gary Smith at the Center for Injury Research and Policy, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio.

    According to Smith, “In 2015, US poison control centers received >25800 calls involving exposures to amphetamine and methylphenidate, which are 2 medications used in the treatment of ADHD […] Stimulant medication overdoses can result in a variety of symptoms, including mydriasis, tremor, agitation, tachycardia, hyperreflexia, confusion, hallucinations, hyperthermia, and status epilepticus.”

The number of reported children inadvertently exposed to stimulant medications rose 71.2% between 2000 and 2011, before dropping slightly by 6.2% between 2011 and 2014. The researchers found that almost half (41.6%) of the exposures were due to unintentional therapeutic error, while another 39.6% were rated as accidental general exposure.

Most of the exposures for children younger than 5 were due to unintentional general exposure (for instance, they may have taken a sibling’s medication while playing), while most of the exposures for older children were due to therapeutic error (took a larger dose or more doses than prescribed, for instance). Intentional exposures were responsible for more than half (50.2%) of the calls for adolescents aged 13 to 19 years old (e.g., medication abuse and suicide attempts).

Twenty-eight percent of the calls involved documented clinical effects (such as drowsiness, irritability, tachycardia, and vomiting). In most cases, these effects were not serious, although 9.4% of the calls involved severe medical problems. The three reported deaths were all due to intentional exposures.

It is worth noting that this is an underestimate of the dangerous exposures to stimulant medications since not all exposures are reported to poison control centers.
“Unintentional and intentional pediatric exposures to ADHD medications are an increasing problem in the United States, affecting children of all ages,” the researchers write. “Exposures associated with suspected suicide or medication abuse and misuse among adolescents are of particular concern.”

****
King, S. A., Casavant, M. J., Spiller, H. A., Hodges, N. L., Chounthirath, T., & Smith, G. A. (2018). Pediatric ADHD medication exposures reported to US poison control centers. Pediatrics, 141(6), e20173872. doi: 10.1542/peds.2017-3872 (Link)


Thank You Mr Simons and MIA.

Thursday, August 9, 2018

Valproate Linked To Decreased Brain Volume In Children Diagnosed With Bipolar Disorder

mad in america
Nevertheless, these studies have mainly examined the effects of valproate on adults diagnosed with bipolar disorder. The researchers of this study sought to investigate further the mechanisms of valproate in children diagnosed with pediatric bipolar disorder (PBD). Neuroimaging scans were used to examine several brain regions pre and post valproate administration. The valproate was titrated to standard clinical levels over a six-week period.
“VPA was started at 250 mg orally twice daily, and titrated as clinically appropriate, on a weekly basis, to reach therapeutic levels (valproate 50–125 ng/mL),” the authors explain.
The sample included 14 children (mean age = 13.43 ± 3.05 years old), 10 of which were males. Criteria included participants that were not taking medication for the two weeks prior, except for lorazepam and ADHD drugs, and that participants met DSM-IV criteria for BD I, BP II or BP-NOS disorder. Other inclusion and exclusion criteria featured details about participants’ medical history and co-occurring diagnoses, among others.

Results demonstrated a decrease in brain volume over time across all participants in a region associated with emotion processing. This interaction effect between time and brain changes was significant in the amygdala.

These contradictory findings, the authors note, could be a result of varying dosages of valproate used across studies.
“Our findings may also appear against the neuroprotective and neurotrophic effects of VPA reported in the literature,” they write.
They suggest future research to explore these results:
“Future large-scale, placebo-controlled, randomized studies with a longer treatment period (>12 weeks) are needed to explore this interpretation and confirm our results which are limited by the short treatment period. It would provide insight into the short and long-term effects of VPA on treatment response and brain developmental trajectory in PBD.”

****
Cazala, F., Suchting, R., Zeni, C. P., Bauer, I. E., Mwangi, B., Wu, M. J., … & Soares, J. C. (2018). Effects of Valproate on brain volumes in pediatric bipolar disorder: a preliminary study. Psychiatry Research: Neuroimaging. (Link)


Thank You Ms Morrill and MIA, 

Thursday, February 1, 2018

Education Committee Meeting Explores Dangers of Govt. Sharing of Data On Kids

Get the non-conformists whatever professional negative reinforcement the State wants them to get.

freebeacon
Charles Fain Lehman 

Feb 1, 2018

Expert: 'This might happen in some place such as China, but it should not happen here'


Experts warned the House Committee on Education and the Workforce Tuesday about threats to the privacy rights of children posed by a proposed expansion of government data sharing as applied to education policies.

The hearing followed the release, in early September of last year, of the final report of the Commission on Evidence-Based Policymaking. Congress created the commission in 2016 to "develop a strategy for increasing the availability and use of data in order to build evidence about government programs, while protecting privacy and confidentiality."

The commission's proposals focused on balancing more effective collection and use of data with a deference to privacy concerns. It called for the creation of a National Secure Data Service, which would facilitate temporary data sharing in support "of distinct authorized projects." Although restricted by "stringent privacy qualifications" for the combining and use of survey data, the NSDS and other government entities would be charged with aggregating and combining data for "statistical purposes," which are otherwise separated.

The commission also called for consideration of repealing current bans and limiting future bans on the collection and use of data. It further called on relevant federal departments to make state-level data available for statistical purposes, and to "direct states to provide the data necessary to support evidence building, such as complete administrative data when samples are already provided."
Despite the commission's insistence on caution, some have objected that the scaling up of such data collection could pose a threat to liberty and privacy, especially in the domain of data collected on America's schoolchildren.

"Education research can be a powerful tool to help our students, but that information should not come at the cost of a student's private and personal information," said Committee Chairwoman Virginia Foxx (R., N.C.). "The changing nature of data use and technology for educational purposes, the use of evidence and research in policymaking, and the public’s consistent call for privacy protections over student data are why we are here today."

Dr. Neal Finkelstein, a senior program director at a San-Francisco-based education research, development, and service agency, and one of the panelists, emphasized the real, positive impacts that better data aggregation has had on his and other education researchers' work.

"Over the past 15 years, the Institute of Education Sciences (IES) has made significant strides promoting and increasing the amount of rigorous evidence available to education decision makers," he said.

"Not only have education researchers applied methods from these fields to questions in education and social science, but we are now conducting studies with greater precision and speed than ever before," Finkelstein said.

Jane Robbins, senior fellow at American Principles Project, said the expansion of a data collection regime posed a threat to the privacy that inheres in every American’s human dignity.

"Each American citizen is endowed with dignity and autonomy, and therefore deserves respect and deference concerning his or her own personal data," Robbins said. "Allowing the government to vacuum up mountains of such data and employing it for whatever purposes it deems useful, without the citizens consent, or in some cases even his knowledge, conflicts deeply with this truth about the dignity of persons."

Robbins cautioned that even the most stringent security and privacy protocols still presented the possibility of abuse, simply by virtue of the aggregation of data and their being placed in human hands.

"Data turned over by citizens for one purpose can be misused for others. It is always assumed that the data will be used in benevolent ways, for the good of the individual who provides it. But especially with respect to the enormous scope of pre-k through college education data, that simply isn't true," she said.

"There are myriad examples of government employees violating statute or policy by misusing or wrongfully disclosing data. And even if the custodians have only good intentions, what they consider appropriate use or disclosure may conflict diametrically with what the affected citizen considers appropriate," Robbins said.

"Speaking for the millions of parents with whom we work in various states, whose concerns about education policy and data have been minimized by various levels of government for years, I encourage you to maintain the protections against treating their children as subjects for research without their consent," Robbins concluded. "This might happen in some place such as China, but it should not happen here."

This entry was posted in Issues and tagged Department of Education, Education. Bookmark the permalink


Thank You Mr Lehman and Free Beacon.

Wednesday, February 25, 2015

NO Proven Treatments of ANY Kind For Psychosis or Schizophrenia In Children or Youth

madinamerica;

There are no proven treatments of any kind for children or adolescents experiencing psychosis or schizophrenia, according to a systematic review and meta-analysis of randomized comparison trials published in PLOS One.
The study was led by researchers from the UK Royal College of Psychiatrists National Collaborating Centre for Mental Health as part of the development of guidelines for psychosis in children, adolescents and young adults.
The researchers examined randomized trials "comparing any pharmacological, psychological, or combined intervention for psychosis and schizophrenia in children, adolescents and young adults", assessed them for bias, and evaluated them according to a variety of outcomes. They identified twenty-seven trials including 3,067 participants.
They found only "low quality" evidence that antipsychotic medications may have "small beneficial effects on psychotic symptoms." However, they found strong evidence that these drugs caused significant weight gain and other adverse side effects.
"There were no trials of psychological treatments in under-18 year olds," they wrote. "There was no evidence of an effect of psychological interventions on psychotic symptoms in an acute episode, or relapse rate."
"For children, adolescents and young adults, the balance of risk and benefit of antipsychotics appears less favourable than in adults," they concluded. "Research is needed to establish the potential for psychological treatments, alone and in combination with antipsychotics, in this population."
Stafford, Megan R., Evan Mayo-Wilson, Christina E. Loucas, Anthony James, Chris Hollis, Max Birchwood, and Tim Kendall. “Efficacy and Safety of Pharmacological and Psychological Interventions for the Treatment of Psychosis and Schizophrenia in Children, Adolescents and Young Adults: A Systematic Review and Meta-Analysis.” Edited by Inez Myin-Germeys. PLOS ONE 10, no. 2 (February 11, 2015): e0117166. doi:10.1371/journal.pone.0117166. (Full text)
--Rob Wipond, News Editor


RELATED POSTS

Thank You Mr Wipond and MIA.

You can't 'treat' an 'Illness' or disease which is neither.

Saturday, February 21, 2015

J&J Hid Risks Of Boy Breast Development, Jury Told

Bloomberg;

  and 


(Bloomberg) -- Johnson & Johnson, which paid more than $2 billion to resolve a criminal probe over its antipsychotic drug Risperdal, knew the medicine caused boys to develop female breasts and failed to alert regulators, doctors and patients, a lawyer argued.
J&J kept quiet about research showing Risperdal caused abnormal breast development in boys to protect billions of dollars in sales of the drug, an attorney for the parents of an autistic man who developed size 46 DD breasts while on the medicine told a jury Friday. J&J misled the U.S. Food and Drug Administration about the antipsychotic’s safety, he added.
“All of you know something the FDA still doesn’t know and that is the increased statistical risk of kids on Risperdal” developing abnormal breasts, the lawyer, Thomas Kline, told jurors during closing statements at a Philadelphia trial over the drugmaker’s handling of the product.
J&J, based in New Brunswick, New Jersey, faces more than 1,000 cases over the Risperdal side effect in state court in Philadelphia. The current case is the first in which a jury will decide whether J&J and its Janssen unit are liable for mishandling the medicine.
In 2012, the company settled the first case to go to trial in Philadelphia over claims Risperdal caused gynecomastia, or abnormal breast development, and has settled at least five other cases over allegations involving the drug.

Saturday, February 7, 2015

$13 Billion in California Mental Health Funding Wasted

$Billions Wasted. Mental Health. Anyone Surprised?
madinamerica;

"State and county officials cannot show how billions of dollars collected through a voter-approved tax on millionaires are being spent or whether the related programs have helped people with mental illness as voters intended," reported CBS Los Angeles, in the wake of an investigation by an independent state oversight commission.
"The Little Hoover Commission report is the latest review to find that the state has little evidence to show that $13 billion in Proposition 63 funds have been effectively spent," said CBS.
According to the Proposition 63 website, the Mental Health Services Act was a successful proposition put before California voters in 2004 to tax people who earned over $1 million, "with the intention of expanding services while improving the quality of life for Californians living with or at risk of serious mental illness."
The recent Commission investigation found that its not clear what most of the money has been put towards, or if there have been positive outcomes, as result of "weak oversight," "poor transparency" and lack of fiscal accountability throughout the program. "In a report to Governor Brown and the Legislature, the Commission cited anecdotal stories of significant successes and improvements in California’s mental health system, but found the state still cannot definitively quantify who has been helped by Proposition 63 spending and how," stated a Commission press release.
State Fails To Track Billions In Mental Health Funds (CBS Los Angeles, January 27, 2015)
--Rob Wipond, News Editor

This entry was posted in Featured News, In the News. Bookmark the permalink.

RELATED POSTS



Thursday, January 29, 2015

There Are NO Proven Psychosocial Therapies That Reduce Self-Harming In Teens

madinamerica;
Another FAIL from the Collectivist, Junk Medical wing  of America's Political Collectivist Fraudsters.


There are no psychosocial treatments or psychotherapeutic methods that are proven to effectively reduce thoughts and behaviors of self-harm in youth, according to a review of the scientific literature by a team of Harvard University psychologists publishing in the Journal of Clinical Child & Adolescent Psychology.
The researchers identified 29 studies published before June of 2013 that examined treatment interventions for suicidal or self-injurious thoughts and behaviors in children or adolescents. They then evaluated the studies using the evidence-based treatment evaluation criteria of the Journal of Clinical Child and Adolescent Psychology. They found that not a single intervention met the Level 1 standard for "well-established treatments."
However, six types of treatment were found to be "probably efficacious" or "possibly efficacious" for reducing self-injurious thoughts and behaviors. "These treatments came from a variety of theoretical orientations," noted the researchers, "including cognitive-behavioral, family, interpersonal, and psychodynamic theories."
Since none of these methods were better than the others, the researchers speculated that the relative efficacy they did have was likely due to common elements among them. For example, most of the different therapeutic strategies involved skills training such as problem solving and emotional regulation, targeted interpersonal relationship dynamics, and included families in the therapy sessions. The strategies also tended to be relatively "intensive," in that they involved multiple meetings per week with therapists.
Glenn, Catherine R., Joseph C. Franklin, and Matthew K. Nock. “Evidence-Based Psychosocial Treatments for Self-Injurious Thoughts and Behaviors in Youth.” Journal of Clinical Child & Adolescent Psychology 44, no. 1 (January 2, 2015): 1–29. doi:10.1080/15374416.2014.945211. (Abstract)




Pennsylvania Celebrates Diversity! Dem Governor Appoints Transgender Doctor To Be State's Next Physician General


With the governor’s office claiming it has nothing to do with her being a transgender…. I know, stop laughing.
Via Newsmax:
A transgender physician will soon become Pennsylvania’s new physician general, the Washington Blade reported.
Dr. Rachel Levine, an expert in adolescent eating disorders and behavior health, was nominated for the Commonwealth’s highest medical post by progressive Gov. Tom Wolf.
She made her transition from man to woman five years ago, and with her appointment will become “the highest-ranking transgender person to ever hold a position within state government,” the Blade said.
Levine graduated from Harvard College and Tulane University Medical School, and has practiced pediatrics and psychiatry for about three decades, PennLive reported. She has been a physician at Penn State Milton S. Hershey Medical Center since 1996 and also serves as a professor of pediatrics and psychiatry at the Penn State College of Medicine, the website site.
The governor’s spokesman said Levine was chosen because of her expertise, not because she is transgender, The American Mirror reported.
“Dr. Rachel Levine is well-respected in the fields of pediatrics, psychiatry, and behavioral health, where she has practiced for close to three decades,” the governor said in statement about her selection.
HT: BCF
Thank You Zip and Newsmax

You'd hope, but of course it would be a false hope, that the people who appointed Rachel would have done their homework on the "Mental Health" of Transgenders before they put her/him into the post of State's Physician General, who, unless we're mistaken, will have Something to do with shelling out Millions of OPM to Diagnose and Treat other people to a dose of "Mental Health".

Wednesday, August 27, 2014

California Foster Children Drugged At "Alarming" Rate

madinamerica;




August 26, 2014

San Jose Mercury News has published the first of a four-part series of investigative articles about the psychotropic drugging of California children. “A year of interviews with foster youth, caregivers, doctors, researchers and legal advocates uncovered how the largest foster care system in the U.S. has grown dependent on quick-fix, taxpayer-funded, big-profit pharmaceuticals — and how the state has done little to stop it,” reports the newspaper in part one.
San Jose Mercury News discovered that 12.2 percent of California foster children are being described two or more psychotropic medications at a time, while more than half of those who live in residential group homes — and as many as 100 percent in some counties — are authorized by juvenile courts to be given psychotropic drugs.
“To be prescribing these medications so extensively and so, I think, thoughtlessly, with so little evidence supporting their use, it’s just malpractice,” one Berkeley child psychiatrist told the San Jose Mercury News. “It really is drugging them.”
The newspaper also reports that the government has been resistant to providing key data about the practices.
Drugging Our Kids (San Jose Mercury News, August 2014)
This entry was posted in Children and AdolescentsFeatured NewsIn the NewsOver-diagnosis by Rob Wipond. Bookmark the permalink.
Thank you Mr Wipond and MIA






Medicate Your Children To Guarantee Compliance With State Objectives

California Tax Officials Stunned By Latest Revenue Decline